KBC Group’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.21M Buy
129,427
+28,693
+28% +$2.26M 0.02% 358
2025
Q4
$8.26M Buy
100,734
+28,419
+39% +$2.21M 0.02% 390
2025
Q3
$5.43M Buy
72,315
+861
+1% +$64.2K 0.01% 436
2025
Q2
$5.29M Sell
71,454
-2,529
-3% -$176K 0.01% 437
2025
Q1
$5.97M Sell
73,983
-133,857
-64% -$11.5M 0.02% 424
2024
Q4
$16.2M Buy
207,840
+23,582
+13% +$2M 0.04% 306
2024
Q3
$17.3M Buy
184,258
+118,214
+179% +$9.92M 0.05% 289
2024
Q2
$5.15M Buy
66,044
+25,197
+62% +$2.06M 0.02% 426
2024
Q1
$3.71M Sell
40,847
-310,078
-88% -$25.8M 0.01% 501
2023
Q4
$27.1M Sell
350,925
-2,197
-0.6% -$154K 0.1% 214
2023
Q3
$24M Buy
353,122
+243,670
+223% +$17.7M 0.1% 213
2023
Q2
$8.89M Sell
109,452
-8,536
-7% -$681K 0.04% 369
2023
Q1
$9.68M Buy
+117,988
New +$8.42M 0.04% 356

Other funds holding GEHC

KBC Group's GEHC Position: Q1 2026 in Review

KBC Group increased its GE HealthCare (GEHC) stake by 28% in Q1 2026, buying an estimated $2.26M and bringing the position to 129,427 shares worth $9.21M. The position accounts for 0.02% of the portfolio, ranked #358.

KBC Group first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $27.1M in Q4 2023. 1,265 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • KBC Group held 129,427 shares of GE HealthCare worth $9.21M as of Q1 2026.
  • KBC Group bought 28,693 GE HealthCare shares in Q1 2026, an estimated $2.26M.
  • GE HealthCare made up 0.02% of KBC Group's portfolio in Q1 2026, its #358 holding.
  • KBC Group first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • KBC Group's GE HealthCare position peaked at $27.1M in Q4 2023.
  • 1,265 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.